MADELEINE TRAN: Open Payments
NPI 1154192599 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,628 in 117 payments from 25 companies in 2025. Trend: 2023 $20 · 2024 $2,566 · 2025 $2,628
Food & beverage: $2,628
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $445 |
| AstraZeneca Pharmaceuticals LP | 10 | $315 |
| Gilead Sciences, Inc. | 9 | $224 |
| Baxter Healthcare | 4 | $201 |
| Sumitomo Pharma America, Inc. | 17 | $171 |
| Novo Nordisk Inc | 8 | $157 |
| ABBVIE INC. | 6 | $144 |
| Verona Pharma, Inc. | 6 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $106 |
| PFIZER INC. | 5 | $106 |
Products named: REPATHA, OTEZLA, AIRSUPRA, GEMTESA, Ohtuvayre, JARDIANCE, Hillrom - Carnation Ambulatory Monitor, Ozempic.
Industry payments across VA — which companies pay providers there.
